May 6, 2022
Coupled with a lack of sufficient prevention strategies and clinical interventions for age-related diseases, the enormous growth of the elderly population poses a significant socioeconomic and healthcare challenge worldwide. With life expectancy rising across the globe – save for the short-term declines caused by the COVID-19 pandemic – more patients are expected to suffer from disease and disability in later life and for more years than before.
As a result, the focus of medicine is expanding to include not just the treatment of acute or chronic illness but also the long-term maintenance of health. The development of modalities for reducing age-associated morbidities and disabilities has become a primary target for investment and innovation in the scientific field.
December 17, 2021
Yet another year is coming to a close, marking another groundbreaking year in medicine. 2021 continued to test the healthcare system and its dedicated professionals with COVID-19 surges and viral variants, rising cases of chronic disease, and nationwide health crises demanding immediate attention.
In line with the A4M mission to disseminate the latest knowledge in modern medicine, we strive to keep clinicians up to date and well-equipped to tackle any clinical challenge with our weekly blog articles. From the role of hormonal health in immunocompetence to the latest successes in Alzheimer’s disease therapeutics, topics featured on the A4M blog highlight essential developments in the industry. To wrap up the year, we compiled a list of our readers’ favorite blogs from 2021.
October 29, 2021
One of the primary limitations of stem cell treatment and the subject of ongoing research is the challenge of directing stem cells to their necessary destination in the body which has been a subject of ongoing research. Prior studies have discovered that stem cells are drawn to inflammation in the body, however, using this as a therapeutic lure still poses risks. Thus, researchers continue their search for tools that would aid stem cells in their migration and conversion into specific types of cells necessary for optimal treatment. The ability to do so would have a wide range of implications for regenerative medicine as well as the treatment of disorders in which inflammatory signals fade over time, such as chronic spinal cord injury, stroke, or conditions in which the role of inflammation remains unknown. Continue reading